Protein Phosphatase 2A Inhibiting β-Catenin Phosphorylation Contributes Critically to the Anti-renal Interstitial Fibrotic Effect of Norcantharidin

[1]  J. Egido,et al.  Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy. , 2019, Kidney international.

[2]  Xinzhong Huang,et al.  Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting β‐catenin activity , 2019, Journal of cellular and molecular medicine.

[3]  D. Barber,et al.  β-Catenin is a pH sensor with decreased stability at higher intracellular pH , 2018, The Journal of cell biology.

[4]  C. Mitchell,et al.  &bgr;-catenin ablation exacerbates polycystic kidney disease progression , 2018, Human molecular genetics.

[5]  Ming Wang,et al.  Novel inhibitors of the cellular renin‐angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β‐catenin pathway against renal fibrosis , 2018, British journal of pharmacology.

[6]  A. A. Abdel Moneim,et al.  Ziziphus spina-christi (L.) leaf extract alleviates myocardial and renal dysfunction associated with sepsis in mice. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  Christopher S. Williams,et al.  Protein Phosphatase 2A in the Regulation of Wnt Signaling, Stem Cells, and Cancer , 2018, Genes.

[8]  Oscar Cerda,et al.  TRPM4 regulates Akt/GSK3‐β activity and enhances β‐catenin signaling and cell proliferation in prostate cancer cells , 2017, Molecular oncology.

[9]  Junwei Yang,et al.  FHL2 promotes tubular epithelial‐to‐mesenchymal transition through modulating β‐catenin signalling , 2017, Journal of cellular and molecular medicine.

[10]  Ashutosh Kumar Singh,et al.  Discovery of a Novel Small-Molecule Inhibitor that Targets PP2A–β-Catenin Signaling and Restricts Tumor Growth and Metastasis , 2017, Molecular Cancer Therapeutics.

[11]  A. Webster,et al.  Chronic Kidney Disease , 2017, The Lancet.

[12]  Yasser S. El-Sayed,et al.  Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats , 2017, Naunyn-Schmiedeberg's Archives of Pharmacology.

[13]  Abdelazim Ibrahim,et al.  Nephroprotective effect of bee honey and royal jelly against subchronic cisplatin toxicity in rats , 2016, Cytotechnology.

[14]  Yingfeng Wan,et al.  Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma. , 2016, Oncology reports.

[15]  M. Abdel-Daim,et al.  Antagonistic effects of Spirulina platensis against sub-acute deltamethrin toxicity in mice: Biochemical and histopathological studies. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  Lin Sun,et al.  Norcantharidin inhibits renal interstitial fibrosis by downregulating PP2Ac expression. , 2015, American journal of translational research.

[17]  A. Zentella,et al.  Protein phosphatase 2A is essential to maintain active Wnt signaling and its Aβ tumor suppressor subunit is not expressed in colon cancer cells , 2015, Molecular carcinogenesis.

[18]  Yaping Zhang,et al.  Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer , 2015, Medical Oncology.

[19]  M. Abdel-Daim,et al.  Synergistic protective effects of ceftriaxone and ascorbic acid against subacute deltamethrin-induced nephrotoxicity in rats , 2015, Renal failure.

[20]  Yibing Yan,et al.  HSP105 Recruits Protein Phosphatase 2A To Dephosphorylate β-Catenin , 2015, Molecular and Cellular Biology.

[21]  L. Yao,et al.  High Phosphorus Level Leads to Aortic Calcification via β-Catenin in Chronic Kidney Disease , 2015, American Journal of Nephrology.

[22]  Youhua Liu,et al.  Wnt/β-catenin signaling and kidney fibrosis , 2014, Kidney international supplements.

[23]  A. Shimono,et al.  Secreted Frizzled-related Protein 1 (Sfrp1) Regulates the Progression of Renal Fibrosis in a Mouse Model of Obstructive Nephropathy* , 2014, The Journal of Biological Chemistry.

[24]  M. Karsdal,et al.  The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? , 2014, Fibrogenesis & tissue repair.

[25]  Xuehao Wang,et al.  Cantharidin Exerts Anti-Hepatocellular Carcinoma by Mir-214 Modulating Macrophage Polarization , 2014, International journal of biological sciences.

[26]  U. Schumacher,et al.  Pharmacogenomics of cantharidin in tumor cells. , 2014, Biochemical pharmacology.

[27]  C. Bao,et al.  Aberrant Activation of the WNT/β-Catenin Signaling Pathway in Lupus Nephritis , 2014, PloS one.

[28]  Zhi-Hong Liu.  Nephrology in China , 2013, Nature Reviews Nephrology.

[29]  Y. Li,et al.  Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition , 2013, PloS one.

[30]  Jian Dong,et al.  Exploiting protein phosphatase inhibitors based on cantharidin analogues for cancer drug discovery. , 2013, Mini reviews in medicinal chemistry.

[31]  Jianfeng Cai,et al.  Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways , 2013, Cancer science.

[32]  L. Pannell,et al.  DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin , 2012, Oncogene.

[33]  L. Deng,et al.  A Review for Mini-Review in Medicinal Chemistry. , 2012, Mini-Reviews in Medical Chemistry.

[34]  Josef Coresh,et al.  Chronic kidney disease , 2012, The Lancet.

[35]  G. Ling,et al.  Norcantharidin inhibits the expression of extracellular matrix and TGF-β1 in HK-2 cells induced by high glucose independent of calcineurin signal pathway , 2011, Laboratory Investigation.

[36]  Youhua Liu.  Cellular and molecular mechanisms of renal fibrosis , 2011, Nature Reviews Nephrology.

[37]  M. Kahn,et al.  Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis. , 2011, Journal of the American Society of Nephrology : JASN.

[38]  G. Ling,et al.  Norcantharidin Attenuates Tubulointerstitial Fibrosis in Rat Models with Diabetic Nephropathy , 2011, Renal failure.

[39]  J. López-Novoa,et al.  An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. , 2010, Kidney international.

[40]  Y. Li,et al.  Norcantharidin Ameliorates Proteinuria, Associated Tubulointerstitial Inflammation and Fibrosis in Protein Overload Nephropathy , 2008, American Journal of Nephrology.

[41]  J. Misset,et al.  Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells. , 1995, European journal of cancer.

[42]  M. Li,et al.  ILK participates in renal interstitial fibrosis by altering the phenotype of renal tubular epithelial cells via TGF-β1/smad pathway. , 2019, European review for medical and pharmacological sciences.

[43]  G. Narla,et al.  Therapeutic targeting of PP2A. , 2018, The international journal of biochemistry & cell biology.

[44]  Yongping Wang,et al.  Wnt Signaling in Kidney Development and Disease. , 2018, Progress in molecular biology and translational science.

[45]  C. Xing,et al.  The wnt/β-catenin signaling pathway participates in rhein ameliorating kidney injury in DN mice , 2015, Molecular and Cellular Biochemistry.

[46]  E. Neilson,et al.  Mechanisms of tubulointerstitial fibrosis. , 1991, Kidney international.